High-risk antimicrobial prescriptions among ambulatory patients on warfarin

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 2, 2012, Pages 157-160

  Lane, M A ^a   Devine, S T ^b   McDonald, J R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Express Scripts   (United States)

Author keywords

Antibiotics; Anticoagulation; Antimicrobials; Drug drug interactions; Warfarin

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; WARFARIN;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT CARE; PHARMACEUTICAL CARE; PRESCRIPTION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; COHORT STUDIES; DATABASES, FACTUAL; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; WARFARIN;

EID: 84857995541     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01270.x     Document Type: Article

References (24)

1. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. New England Journal of Medicine, 1990;323:1505-1511.
2. Stroke Prevention in Atrial Fibrillation Investigators Stroke prevention in atrial fibrillation study. Final results. Circulation, 1991;84:527-539.
3. Ezekowitz MD, Bridgers SL, James KE et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators. New England Journal of Medicine, 1992;327:1406-1412.
4. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The copenhagen AFASAK study. Lancet, 1989;1:175-179. (Pubitemid 19038801)
5. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ Antithrombotic therapy for venous thromboembolic disease*. Chest, 2008;133:454S-545S.
6. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the society of cardiovascular anesthesiologists endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Journal of the American College of Cardiology, 2006;48:e1-e148. (Pubitemid 44109952)
7. Schulman S Clinical practice. Care of patients receiving long-term anticoagulant therapy. New England Journal of Medicine, 2003;349:675-683.
8. Schulman S, Beyth RJ, Kearon C, Levine MN Hemorrhagic complications of anticoagulant and thrombolytic treatment: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest, 2008;133:257S-298S. (Pubitemid 351892969)
9. Linkins LA, Choi PT, Douketis JD Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Annals of Internal Medicine, 2003;139:893-900.
10. Hirsh J, Dalen J, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 2001;119:8S-21S. (Pubitemid 32154192)
11. Micromedex (2009) In: Micromedex, Vol.
12. Holbrook AM, Pereira JA, Labiris R et al. Systematic overview of warfarin and its drug and food interactions. Archives of Internal Medicine, 2005;165:1095-1106. (Pubitemid 40720733)
13. Glasheen JJ, Fugit RV, Prochazka AV The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. Journal of General Internal Medicine, 2005;20:653-656. (Pubitemid 41026254)
14. Visser LE, Penning-van Bees FJ, Kasbergen AA et al. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thrombosis and Haemostasis, 2002;88:705-710. (Pubitemid 35345323)
15. O'Reilly RA The stereoselective interaction of warfarin and metronidazole in man. New England Journal of Medicine, 1976;295:354-357.
16. Kunze KL, Wienkers LC, Thummel KE, Trager WF. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. Drug Metabolism and Disposition, 1996;24:414-421.
17. Black DJ, Kunze KL, Wienkers LC, et al. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. Drug Metabolism and Disposition, 1996;24:422-428.
18. Israel DS, Stotka J, Rock W et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. Clinical Infectious Diseases, 1996;22:251-256. (Pubitemid 26056152)
19. Von Korff M, Wagner EH, Saunders K A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology, 1992;45:197-203.
20. Johnson RE, Hornbrook MC, Nichols GA Replicating the chronic disease score (CDS) from automated pharmacy data. Journal of Clinical Epidemiology, 1994;47:1191-1199. (Pubitemid 24322815)
21. Penning-van Beest FJ, Koerselman J, Herings RM Quantity and quality of potential drug interactions with coumarin anticoagulants in the Netherlands. Pharmacy World & Science, 2007;29:671-675. (Pubitemid 47594178)
22. Hylek EM, Singer DE Risk factors for intracranial hemorrhage in outpatients taking warfarin. Annals of Internal Medicine, 1994;120:897-902. (Pubitemid 24179151)
23. Fang MC, Chang Y, Hylek EM et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Annals of Internal Medicine, 2004;141:745-752.
24. Fan VS, Maciejewski ML, Liu CF, McDonell MB, Fihn SD Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Services and Outcomes Research Methodology, 2006;6:21-36. (Pubitemid 44824566)